These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 27339602)
21. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747 [TBL] [Abstract][Full Text] [Related]
22. [Telomere and telomerase in human cancer]. Hiyama K; Hiyama E; Ishioka S; Yamakido M Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230 [TBL] [Abstract][Full Text] [Related]
23. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Kelland L Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545 [TBL] [Abstract][Full Text] [Related]
24. [Telomerase: an enzyme with multiple applications in cancer research]. Castillo Ureta H; Barrera Saldaña HA; Martínez Rodríguez HG Rev Invest Clin; 2002; 54(4):342-8. PubMed ID: 12415959 [TBL] [Abstract][Full Text] [Related]
25. Telomeres and telomerase as targets for cancer therapy. Zimmermann S; Martens UM Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277 [TBL] [Abstract][Full Text] [Related]
26. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer. Sekhri K J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374 [TBL] [Abstract][Full Text] [Related]
27. Telomerase and telomeres: from basic biology to cancer treatment. Helder MN; Wisman GB; van der Zee GJ Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380 [TBL] [Abstract][Full Text] [Related]
28. Telomeres and telomerase: Pharmacological targets for new anticancer strategies? Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544 [TBL] [Abstract][Full Text] [Related]
30. [Telomeres and telomerase as targeted therapies in cancer treatment]. Souiden Y; Bouraoui A; Chaieb K; Mahdouani K Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741 [TBL] [Abstract][Full Text] [Related]
31. Telomere maintenance as a target for drug discovery. Sekaran V; Soares J; Jarstfer MB J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596 [TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Rankin AM; Faller DV; Spanjaard RA Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043 [TBL] [Abstract][Full Text] [Related]
33. [Advance of research on telomerase]. Hiyama K; Ishioka S; Hiyama E; Yamakido M Gan To Kagaku Ryoho; 1998 Jul; 25(8):1105-10. PubMed ID: 9679570 [TBL] [Abstract][Full Text] [Related]
34. Recent patents on anti-telomerase cancer therapy. Agrawal A; Dang S; Gabrani R Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360 [TBL] [Abstract][Full Text] [Related]
35. Telomerase inhibitors for the treatment of cancer: the current perspective. Perry PJ; Arnold JR; Jenkins TC Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310 [TBL] [Abstract][Full Text] [Related]
36. Oligonucleotides Targeting Telomeres and Telomerase in Cancer. Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661 [TBL] [Abstract][Full Text] [Related]
37. Targeting telomerase. Siddiqa A; Cavazos DA; Marciniak RA Rejuvenation Res; 2006; 9(3):378-90. PubMed ID: 16859479 [TBL] [Abstract][Full Text] [Related]
39. Telomerase: a target for cancer therapeutics. Shay JW; Wright WE Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889 [TBL] [Abstract][Full Text] [Related]
40. Targeting telomerase for cancer therapy. Guterres AN; Villanueva J Oncogene; 2020 Sep; 39(36):5811-5824. PubMed ID: 32733068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]